Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $50.4923 (1.89%) ($49.6269 - $50.7572) on Fri. Dec. 4, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.73% (three month average) | RSI | 38 | Latest Price | $50.4923(1.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1% a day on average for past five trading days. | Weekly Trend | ABBV declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) VYM(48%) IBB(47%) IVE(47%) SPY(47%) | Factors Impacting ABBV price | ABBV will decline at least -1.365% in a week (0% probabilities). VIXM(-21%) TLT(-14%) UUP(-10%) IGOV(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.365% (StdDev 2.73%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
1 - 5 Day Possible Target | $45.94(-9.02%) | Resistance Level | $53.09 | 5 Day Moving Average | $50.9(-0.8%) | 10 Day Moving Average | $52.17(-3.22%) | 20 Day Moving Average | $53.09(-4.89%) | To recent high | -10.8% | To recent low | 18.5% | Market Cap | $89.083b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |